Locations:
Search IconSearch

Cancer

Dr. Bukavina smiles at patient in hospital bed

Bladder Cancer Patients’ Microbiomes Can Influence How Chemotherapy Is Metabolized

Findings confirm microbial variability, offer new potential treatment strategy

Chris Weight typing into laptop in office

Artificial Intelligence Tool Informs Prostate Cancer Management

AI histologic classifier reliably predicts clinical risk in men post-prostatectomy

Oncologist consulting with couple
April 29, 2025/Cancer/News & Insight

Are Your Patients With Cancer Experiencing Sexual Dysfunction? Just Ask!

Sexual disorders affect patients across all cancer types

Dr. Khorana
April 25, 2025/Cancer/News & Insight

Molecular Insights into Early-Onset Biliary Tract Cancer (Podcast)

A call for awareness about the importance of genomic testing

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Dr. Melenhorst
April 24, 2025/Cancer/News & Insight

Explore Developments in CAR T-Cell Therapy for CLL (Podcast)

Discussing research into improving CAR T-cell therapy efficacy

Dr. Cherian
April 23, 2025/Cancer/News & Insight

De-intensifying Radiation Therapy in Low-Risk Breast Cancer

Ultra-Hypofractionated Whole Breast Irradiation and Partial Breast Irradiation Reduce Many Toxicities

Pathology image
April 22, 2025/Cancer/News & Insight

Patient Case Study: Second Opinion Reveals Misdiagnosed Cancer

Patient receives liver transplant and a new lease on life

Clinician talking with patient
April 21, 2025/Cancer/News & Insight

Hematology Clinic Created to Support Spanish-Speaking Population

Lutheran Hospital team brings emerging treatments to community setting

Dr. Pennell and patient
April 10, 2025/Cancer/News & Insight

BiTE Therapy Emerges for Treating Small-Cell Lung Cancer

Hybrid treatment model helps improve cancer care access

Immune checkpoint inhibitor illustration
April 8, 2025/Cancer

Building on Initial Trial Data about New Immune Checkpoint Inhibitor for Treating Colorectal Cancer

Insights indicate that treatment may be beneficial beyond MSI-H tumors

BackPage 1 of 112Next

Advertisement

Ad